report "Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030", is valued at an estimated USD 2.76 billion in 2025. The size is projected to reach USD 3.84 billion by 2030, at a CAGR of 6.9%.

Browse 233 market data Tables and 46 Figures spread through 248 Pages and in-depth TOC on "Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030"

Download PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215139824

The market for negative pressure wound therapy is fueled by the increasing prevalence of chronic wounds. Additionally, the upsurging prevalence of diabetes is boosting the market for negative pressure wound therapy. However, the risks associated with the use of negative pressure wound therapy products are restraining the market growth during the forecast period. Additionally, the growing number of emerging markets globally serves as an opportunistic factor for market growth. However, the risk associated with negative pressure wound therapy, such as lack of awareness, is challenging the growth of the negative pressure wound therapy market across the forecast period.

By wound type, the burns and surgical & open wounds segment is expected to grow at the fastest rate in the negative pressure wound therapy market across the forecast period.

The negative pressure wound therapy market is divided into five main segments based on wound type: burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment held the largest market share in 2024. Burns and surgical & open wounds lead the NPWT market because they require advanced wound care solutions to heal the targeted wound properly. These wounds are caused by significant tissue damage, fluid buildup, and can facilitate a high risk of infection. The NPWT devices help by extracting excess fluids, reducing swelling, and creating a maintained environment that supports faster healing and tissue growth.

By end user, hospitals held the largest share in the negative pressure wound therapy market in 2024.

Based on end users, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, the hospitals segment held the largest market share in 2024. The rising incidence of traumatic injuries and post-operative wounds has further stimulated the need for advanced wound care products in hospitals. Hospital visits for wound care have also increased as a result of the growing geriatric population with chronic illnesses, including diabetes and vascular diseases such as diabetic foot ulcer. Hospitals can treat wounds quickly and effectively due to established wound care protocols, knowledgeable medical staff, and a wide range of negative pressure wound therapy products.

North America dominated the global negative pressure wound therapy market in 2024.

The negative pressure wound therapy market is segmented into five major segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America had the largest market share in the negative pressure wound therapy market in 2024. This is due to the increasing prevalence of diabetes, which leads to diabetic foot ulcers in the geriatric population. Additionally, the huge presence of negative pressure wound therapy manufacturing companies in the region is increasing the market growth. The US has also observed a rise in obesity and road accidents, which has boosted the negative pressure wound therapy market in North America.

Key Players

Prominent players in the negative pressure wound therapy market include, Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Mölnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), Advanced Oxygen Therapy Inc. (US), and Carilex Medical (Taiwan).

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.